Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,380 JPY | +0.25% |
|
+4.34% | +39.26% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company is in a robust financial situation considering its net cash and margin position.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- For several months, analysts have been revising their EPS estimates roughly upwards.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- The opinion of analysts covering the stock has improved over the past four months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- The valuation of the company is particularly high given the cash flows generated by its activity.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+39.26% | 520M | - | ||
-6.46% | 179B | C+ | ||
-6.43% | 98.84B | C | ||
-7.28% | 65.34B | A | ||
+15.46% | 45.41B | B+ | ||
-8.93% | 44.94B | B- | ||
+8.19% | 43.76B | B- | ||
+12.00% | 29.01B | B | ||
+19.39% | 25.65B | A- | ||
-9.09% | 23.32B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 4549 Stock
- Ratings Eiken Chemical Co., Ltd.